Screener
TG Therapeutics TGTX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from TG Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's asset turnover?
- TG Therapeutics (TGTX) reported asset turnover of 0.7× in Q2 2026.
- How has TG Therapeutics's asset turnover changed year-over-year?
- TG Therapeutics's asset turnover decreased by 17.0% year-over-year, from 0.8× to 0.7×.
- What is the long-term trend for TG Therapeutics's asset turnover?
- Over 5 years (2020 to 2025), TG Therapeutics's asset turnover has grown at a 351.6% compound annual growth rate (CAGR), from 0× to 0.8×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about TG Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude